The effect of abdominal massage applied on term newborns receiving phototherapy on transcutaneous bilirubin level

Comparison of bilirubin levels and physiologic signs according to abdominal massage intervention on term newborn infants in phototherapy: randomized clinical trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN27769096

Enrollment

Registered

2019-11-08

Start date

2019-10-15

Completion date

Unknown

Last updated

2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperbilirubinemia, Jaundice Neonatal Diseases Hyperbilirubinemia

Interventions

This study has planned to determine the effect of abdominal massage intervention on term newborn infants receiving phototherapy for hyperbilirubinemia on transcutaneous bilirubin levels.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Family willing to participate in the research 2. Birth between gestational weeks > 37 and 2500 and 7 5. Phototherapy treatment for the first time

Exclusion criteria

Exclusion criteria: Physical examination of the newborn performed by the physician and decided to another health problem other than hyperbilirubinemia

Design outcomes

Primary

Measure	Time frame
1. Serum bilirubin level; routinely check every 24 hours in the neonatal unit. 2. Transcutaneous bilirubin level; will check from forehead before starting phototherapy. 3. Oxygen saturation: will check from pulse oximeter before starting phototherapy mean value for one minute after relaxed for 5 minutes 4. Heart rate: checked from pulse oximeter before starting phototherapy mean value for one minute after relaxed for 5 minutes 5. Sounds of bowel movements: the bowel movements will auscultate from over all four quadrants, 1 minute for each quadrant, total 4 minutes. 6. Serum bilirubin measurement will be repeated at the 48th hour of phototherapy after the last massage session (6th Session) -at least 6 hours later - in newborns in the experimental group 7. In newborns in the control group, blood bilirubin measurement will be repeated at 48 hours of phototherapy	—

Measure

Time frame

1. Serum bilirubin level; routinely check every 24 hours in the neonatal unit. 2. Transcutaneous bilirubin level; will check from forehead before starting phototherapy. 3. Oxygen saturation: will check from pulse oximeter before starting phototherapy mean value for one minute after relaxed for 5 minutes 4. Heart rate: checked from pulse oximeter before starting phototherapy mean value for one minute after relaxed for 5 minutes 5. Sounds of bowel movements: the bowel movements will auscultate from over all four quadrants, 1 minute for each quadrant, total 4 minutes. 6. Serum bilirubin measurement will be repeated at the 48th hour of phototherapy after the last massage session (6th Session) -at least 6 hours later - in newborns in the experimental group 7. In newborns in the control group, blood bilirubin measurement will be repeated at 48 hours of phototherapy

—

Secondary

Measure	Time frame
1. Feeding type (breastfeeding or formulated bottle feeding): 1.1 For the newborns who breastfeed: 1.1.1 Duration of breastfeeding (minute) 1.1.2 Test weight of infant (g) 1.1.3 Number of breastfeeding (number/day) will be recorded 1.2 For the newborns who formulated feeding 1.2.1 Duration of feeding (minute) 1.2.2 Number of feeding (number/day) 1.2.3 Amount of each feeding (ml) 2. For both groups, the number of feces will be recorded for 2 days on the observation form	—

Measure

Time frame

1. Feeding type (breastfeeding or formulated bottle feeding): 1.1 For the newborns who breastfeed: 1.1.1 Duration of breastfeeding (minute) 1.1.2 Test weight of infant (g) 1.1.3 Number of breastfeeding (number/day) will be recorded 1.2 For the newborns who formulated feeding 1.2.1 Duration of feeding (minute) 1.2.2 Number of feeding (number/day) 1.2.3 Amount of each feeding (ml) 2. For both groups, the number of feces will be recorded for 2 days on the observation form

—

Countries

Turkey

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026